Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$419M |
| 2 |
Truist Financial
TFC
|
+$351M |
| 3 |
Mastercard
MA
|
+$218M |
| 4 |
PPL
PPL Corp
PPL
|
+$193M |
| 5 |
Cognizant
CTSH
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$592M |
| 2 |
IBM
IBM
|
+$320M |
| 3 |
Wells Fargo
WFC
|
+$306M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$290M |
| 5 |
Walt Disney
DIS
|
+$267M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.49% |
| 2 | Financials | 13.79% |
| 3 | Healthcare | 13.31% |
| 4 | Consumer Discretionary | 10.06% |
| 5 | Industrials | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Repay Holdings
RPAY
$317M
| $433K | ﹤0.01% |
29,589
+17,494
| +145% | +$244K |
|
3502
HBT Financial
HBT
$1.35B
| $432K | ﹤0.01% |
+22,754
| New | +$388K |
|
3503
Aldeyra Therapeutics
ALDX
$86.9M
| $431K | ﹤0.01% |
74,257
-3,290
| -4% | -$19K |
|
|
PTN
3504
Palatin Technologies
PTN
$17.8M
| $430K | ﹤0.01% |
439
-130
| -23% | -$132K |
|
3505
Invesco S&P 500 Pure Value ETF
RPV
$1.74B
| $430K | ﹤0.01% |
6,207
-307
| -5% | -$20.5K |
|
3506
BeyondSpring
BYSI
$41M
| $429K | ﹤0.01% |
27,664
+3,383
| +14% | +$50.2K |
|
|
AFMD
3507
DELISTED
Affimed
AFMD
| $428K | ﹤0.01% |
15,614
+1,825
| +13% | +$48.8K |
|
|
CASA
3508
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $428K | ﹤0.01% |
104,548
-167,567
| -62% | -$800K |
|
3509
Pulse Biosciences
PLSE
$3.2B
| $426K | ﹤0.01% |
31,705
+1,389
| +5% | +$19.8K |
|
3510
iShares Core S&P US Value ETF
IUSV
$28B
| $424K | ﹤0.01% |
+6,728
| New | +$406K |
|
|
SRT
3511
DELISTED
Startek Inc.
SRT
| $423K | ﹤0.01% |
53,024
-888
| -2% | -$6.48K |
|
3512
South Plains Financial
SPFI
$859M
| $422K | ﹤0.01% |
+20,238
| New | +$367K |
|
|
AKRO
3513
DELISTED
Akero Therapeutics
AKRO
| $421K | ﹤0.01% |
18,968
+8,001
| +73% | +$166K |
|
3514
Oak Valley Bancorp
OVLY
$288M
| $421K | ﹤0.01% |
21,633
-329
| -1% | -$5.83K |
|
3515
iShares Bloomberg Roll Select Commodity Strategy ETF
CMDY
$575M
| $420K | ﹤0.01% |
9,308
| – | – |
|
|
NFJ
3516
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.46B
| $420K | ﹤0.01% |
+32,346
| New | +$409K |
|
|
BSMP
3517
DELISTED
Invesco BulletShares 2025 Municipal Bond ETF
BSMP
| $419K | ﹤0.01% |
16,681
-23,319
| -58% | -$584K |
|
3518
First Trust NASDAQ Cybersecurity ETF
CIBR
$16B
| $419K | ﹤0.01% |
13,965
-1,965
| -12% | -$57.4K |
|
3519
Gran Tierra Energy
GTE
$336M
| $419K | ﹤0.01% |
32,460
| – | – |
|
|
LOVE
3520
LoveSac
LOVE
$258M
| $419K | ﹤0.01% |
26,137
-10,335
| -28% | -$161K |
|
3521
Dr. Reddy's Laboratories
RDY
$10.3B
| $416K | ﹤0.01% |
51,245
-45,005
| -47% | -$355K |
|
3522
Aclaris Therapeutics
ACRS
$863M
| $415K | ﹤0.01% |
219,779
+95,527
| +77% | +$158K |
|
3523
ImmunityBio
IBRX
$8.11B
| $414K | ﹤0.01% |
109,141
-1,485
| -1% | -$2.53K |
|
3524
Kinetik
KNTK
$4.16B
| $411K | ﹤0.01% |
14,380
-899
| -6% | -$20.7K |
|
3525
Nomura Holdings
NMR
$29.2B
| $411K | ﹤0.01% |
79,693
+4,306
| +6% | +$20.8K |
|
Similar funds
Bank of New York Mellon's Q4 2019 Portfolio in Review
As of Q4 2019, Bank of New York Mellon held 4,341 positions worth $388B, up 6.4% from $364B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Bank of New York Mellon's Q4 2019 filing shows 131 new, 1,843 increased, 1,854 reduced and 165 closed positions. Its largest new stake was State Street SPDR Bloomberg Emerging Markets Local Bond ETF: 1,648,268 shares worth $46M. The largest sale was Celgene Corp, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q4 2019 buy was State Street SPDR Bloomberg Emerging Markets Local Bond ETF: 1,648,268 shares worth $46M.
- Bank of New York Mellon added most to Bristol-Myers Squibb in Q4 2019, an estimated $419M increase.
- Bank of New York Mellon's biggest Q4 2019 reduction was IBM, cutting an estimated $320M.
- Bank of New York Mellon fully exited Celgene Corp in Q4 2019, selling an estimated $592M.
- Bank of New York Mellon's ten largest holdings make up 16% of its $388B portfolio in Q4 2019.
- Bank of New York Mellon opened 131 new positions and closed 165 in Q4 2019.
- Bank of New York Mellon's portfolio value rose 6.4% quarter-over-quarter to $388B.
Based on Bank of New York Mellon's 13F filing for Q4 2019, filed 14 Feb 2020.